2-132645433-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001508.3(GPR39):c.1189C>T(p.Arg397Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,613,596 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001508.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPR39 | NM_001508.3 | c.1189C>T | p.Arg397Trp | missense_variant | 2/2 | ENST00000329321.4 | NP_001499.1 | |
LYPD1 | NM_144586.7 | c.*612G>A | 3_prime_UTR_variant | 3/3 | ENST00000397463.3 | NP_653187.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPR39 | ENST00000329321.4 | c.1189C>T | p.Arg397Trp | missense_variant | 2/2 | 1 | NM_001508.3 | ENSP00000327417.3 | ||
LYPD1 | ENST00000397463 | c.*612G>A | 3_prime_UTR_variant | 3/3 | 1 | NM_144586.7 | ENSP00000380605.2 | |||
GPR39 | ENST00000470071.1 | n.892C>T | non_coding_transcript_exon_variant | 3/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152184Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000565 AC: 14AN: 247980Hom.: 0 AF XY: 0.0000744 AC XY: 10AN XY: 134386
GnomAD4 exome AF: 0.0000240 AC: 35AN: 1461296Hom.: 0 Cov.: 32 AF XY: 0.0000220 AC XY: 16AN XY: 726992
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152300Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74466
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 30, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at